Detailed information for compound 1748259

Basic information

Technical information
  • Name: Unnamed compound
  • MW: 472.39 | Formula: C17H25N6O8P
  • H donors: 8 H acceptors: 7 LogP: -6.48 Rotable bonds: 13
    Rule of 5 violations (Lipinski): 2
  • SMILES: NC(=O)C[C@@H](C(=O)N)NC(=O)C1(CC1)NC(=O)[C@H](Cc1ccc(c(c1)N)OP(=O)(O)O)N
  • InChi: 1S/C17H25N6O8P/c18-9-5-8(1-2-12(9)31-32(28,29)30)6-10(19)15(26)23-17(3-4-17)16(27)22-11(14(21)25)7-13(20)24/h1-2,5,10-11H,3-4,6-7,18-19H2,(H2,20,24)(H2,21,25)(H,22,27)(H,23,26)(H2,28,29,30)/t10-,11-/m0/s1
  • InChiKey: QXVADDZFHSYLJE-QWRGUYRKSA-N  

Network

Hover on a compound node to display the structore

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens growth factor receptor-bound protein 2 Starlite/ChEMBL References

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Echinococcus multilocularis growth factor receptor bound protein 2 Get druggable targets OG5_131257 All targets in OG5_131257
Schistosoma mansoni growth factor receptor-bound protein Get druggable targets OG5_131257 All targets in OG5_131257
Schistosoma mansoni growth factor receptor-bound protein Get druggable targets OG5_131257 All targets in OG5_131257
Brugia malayi Sex muscle abnormal protein 5 Get druggable targets OG5_131257 All targets in OG5_131257
Loa Loa (eye worm) sex muscle abnormal protein 5 Get druggable targets OG5_131257 All targets in OG5_131257
Schistosoma japonicum ko:K04364 growth factor receptor-binding protein 2, putative Get druggable targets OG5_131257 All targets in OG5_131257
Echinococcus granulosus growth factor receptor bound protein 2 Get druggable targets OG5_131257 All targets in OG5_131257
Schistosoma japonicum Growth factor receptor-bound protein 2, putative Get druggable targets OG5_131257 All targets in OG5_131257

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Leishmania major hypothetical protein, conserved growth factor receptor-bound protein 2 217 aa 200 aa 23.5 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Wolbachia endosymbiont of Brugia malayi amidophosphoribosyltransferase 0.0047 0 0.5
Trypanosoma cruzi hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1
Loa Loa (eye worm) hypothetical protein 0.0303 1 1
Brugia malayi Sex muscle abnormal protein 5 0.0152 0.4103 0.6888
Schistosoma mansoni hypoxanthine-guanine phosphoribosyltransferase 0.02 0.5956 1
Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1
Loa Loa (eye worm) inward rectifying k channel family protein 1 0.0303 1 1
Toxoplasma gondii hypothetical protein 0.0303 1 1
Echinococcus granulosus hypoxanthine guanine phosphoribosyltransferase 0.02 0.5956 1
Treponema pallidum hypothetical protein 0.0047 0 0.5
Giardia lamblia Guanine phosphoribosyltransferase 0.02 0.5956 1
Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase 0.02 0.5956 1
Leishmania major hypoxanthine-guanine phosphoribosyltransferase 0.02 0.5956 1
Trichomonas vaginalis hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1
Treponema pallidum phosphoribosylpyrophosphate synthetase 0.0047 0 0.5
Wolbachia endosymbiont of Brugia malayi orotate phosphoribosyltransferase 0.0047 0 0.5
Plasmodium falciparum hypoxanthine-guanine phosphoribosyltransferase 0.02 0.5956 1
Echinococcus granulosus hypoxanthine guanine phosphoribosyltransferase 0.02 0.5956 1
Schistosoma mansoni growth factor receptor-bound protein 0.0152 0.4103 0.6888
Echinococcus multilocularis hypoxanthine guanine phosphoribosyltransferase 0.02 0.5956 1
Trypanosoma cruzi hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1
Mycobacterium ulcerans hypoxanthine-guanine phosphoribosyltransferase Hpt 0.02 0.5956 1
Onchocerca volvulus 0.02 0.5956 1
Mycobacterium leprae Probable hypoxanthine-guanine phosphoribosyltransferase Hpt (HGPRT) (HGPRTase) (hypoxanthine phosphoribosyltransferase) (IMP pho 0.0153 0.4136 1
Loa Loa (eye worm) sex muscle abnormal protein 5 0.0152 0.4103 0.4103
Toxoplasma gondii hypoxanthine-xanthine-guanine phosphoribosyl transferase HXGPRT 0.02 0.5956 0.5956
Plasmodium vivax hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1
Trypanosoma brucei hypoxanthine-guanine phosphoribosyltransferase 0.02 0.5956 1
Mycobacterium tuberculosis Hypoxanthine-guanine phosphoribosyltransferase Hpt (HGPRT) (HGPRTase) (hypoxanthine phosphoribosyltransferase) (imp pyrophosphor 0.0153 0.4136 1
Leishmania major xanthine phosphoribosyltransferase 0.02 0.5956 1
Brugia malayi Phosphoribosyl transferase domain containing protein 0.02 0.5956 1
Echinococcus multilocularis hypoxanthine guanine phosphoribosyltransferase 0.02 0.5956 1
Schistosoma mansoni growth factor receptor-bound protein 0.0152 0.4103 0.6888
Trypanosoma cruzi hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1
Loa Loa (eye worm) hypothetical protein 0.0303 1 1
Echinococcus multilocularis growth factor receptor bound protein 2 0.0152 0.4103 0.6888
Treponema pallidum adenine phosphoribosyltransferase 0.0047 0 0.5
Schistosoma mansoni hypoxanthine-guanine phosphoribosyltransferase 0.02 0.5956 1
Echinococcus granulosus growth factor receptor bound protein 2 0.0152 0.4103 0.6888
Trypanosoma cruzi hypoxanthine-guanine phosphoribosyltransferase, putative 0.02 0.5956 1

Activities

Activity type Activity value Assay description Source Reference
IC50 (binding) = 124 nM Inhibition of binding to Grb2 SH2 domain ChEMBL. 9599224

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.